PL1680139T3 - Zastosowanie somatostatyny lub jej analogów do wytwarzania leku przeznaczonego do regulowania rezerwy pęcherzyków jajnikowych u kobiet w wieku niemenopauzalnym - Google Patents

Zastosowanie somatostatyny lub jej analogów do wytwarzania leku przeznaczonego do regulowania rezerwy pęcherzyków jajnikowych u kobiet w wieku niemenopauzalnym

Info

Publication number
PL1680139T3
PL1680139T3 PL04791488T PL04791488T PL1680139T3 PL 1680139 T3 PL1680139 T3 PL 1680139T3 PL 04791488 T PL04791488 T PL 04791488T PL 04791488 T PL04791488 T PL 04791488T PL 1680139 T3 PL1680139 T3 PL 1680139T3
Authority
PL
Poland
Prior art keywords
somatostatin
menopausal women
follicles
analogs
reserve
Prior art date
Application number
PL04791488T
Other languages
English (en)
Polish (pl)
Inventor
Alain Gougeon
Ernest Loumaye
Original Assignee
Preglem Sa
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Preglem Sa, Inst Nat Sante Rech Med filed Critical Preglem Sa
Publication of PL1680139T3 publication Critical patent/PL1680139T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL04791488T 2003-10-10 2004-10-08 Zastosowanie somatostatyny lub jej analogów do wytwarzania leku przeznaczonego do regulowania rezerwy pęcherzyków jajnikowych u kobiet w wieku niemenopauzalnym PL1680139T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03292505A EP1522311A1 (de) 2003-10-10 2003-10-10 Verwendung von Somatostatin oder seine Derivate zur Herstellung eines Medikamentes zur Regulierung der Ovarialfollikelnreserve bei der nicht menopausierte Frau
EP04791488A EP1680139B1 (de) 2003-10-10 2004-10-08 Verwendung von somatostatin oder einem der analoga zur herstellung eines medikaments zur regulierung der eierstock-follikel-reserve in nicht-menopausalen frauen
PCT/FR2004/002536 WO2005034989A2 (fr) 2003-10-10 2004-10-08 Utilisation de la somatostatine ou d’un de ses analogues pour preparer un medicament destine a reguler la reserve folliculaire ovarienne chez la femme non menopausee

Publications (1)

Publication Number Publication Date
PL1680139T3 true PL1680139T3 (pl) 2007-08-31

Family

ID=34307036

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04791488T PL1680139T3 (pl) 2003-10-10 2004-10-08 Zastosowanie somatostatyny lub jej analogów do wytwarzania leku przeznaczonego do regulowania rezerwy pęcherzyków jajnikowych u kobiet w wieku niemenopauzalnym

Country Status (12)

Country Link
US (2) US7648961B2 (de)
EP (2) EP1522311A1 (de)
JP (2) JP5572280B2 (de)
AT (1) ATE355851T1 (de)
CA (1) CA2542054C (de)
DE (1) DE602004005229T2 (de)
DK (1) DK1680139T3 (de)
ES (1) ES2284067T3 (de)
PL (1) PL1680139T3 (de)
PT (1) PT1680139E (de)
RU (1) RU2418604C9 (de)
WO (1) WO2005034989A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1522311A1 (de) * 2003-10-10 2005-04-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Verwendung von Somatostatin oder seine Derivate zur Herstellung eines Medikamentes zur Regulierung der Ovarialfollikelnreserve bei der nicht menopausierte Frau
CA2699215A1 (en) 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag (d-leu7 ) -histrelin as a therapeutic agent
US8937152B2 (en) * 2007-12-03 2015-01-20 Italfarmaco Spa Non-selective somatostatin analogues
US20090325863A1 (en) * 2008-06-13 2009-12-31 Kleinberg David L Somatostatin analogs and IGF-I inhibition for breast cancer prevention
WO2011151782A1 (en) * 2010-06-02 2011-12-08 Preglem Sa A role for somatostatin to modulate initiation of follicular growth in the human ovary
WO2012074559A2 (en) 2010-12-02 2012-06-07 New York University Treatment of non-proliferative cystic disease
EP2835136A1 (de) 2013-08-07 2015-02-11 PregLem S.A. Somatostatin Receptor Modulator zur Unfruchtbarkeitsbehandlung
US20200316072A1 (en) * 2017-12-21 2020-10-08 Aarhus Universitet Compounds for use in regulating follicle maturation
RU2722849C1 (ru) 2019-12-25 2020-06-04 Владимир Глебович Лунин Рекомбинантный белок GBD-SSTad-SSTad, способ его получения и применения
CN111785389B (zh) * 2020-07-10 2021-10-19 北京大学第三医院（北京大学第三临床医学院） 预测受试者出现卵巢储备新变化年限的系统和方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides
MY147327A (en) 1995-06-29 2012-11-30 Novartis Ag Somatostatin peptides
JP3784418B2 (ja) * 1996-06-11 2006-06-14 ノバルティス アクチエンゲゼルシャフト ソマトスタチン類似体およびラパマイシンの配合
AU3215597A (en) * 1996-08-30 1998-03-19 Biomeasure Incorporated Method of inhibiting fibrosis with a somatostatin agonist
AU4772497A (en) * 1996-10-31 1998-05-22 Novo Nordisk A/S Constrained somatostatin agonists and antagonists
GB0018891D0 (en) * 2000-08-01 2000-09-20 Novartis Ag Organic compounds
NZ502796A (en) * 2000-06-15 2003-02-28 Agres Ltd Nucleotide and amino acid sequences of oocyte factors related to GDF-9B or GDF-9
ATE362489T1 (de) * 2001-03-06 2007-06-15 Il Consorzio Ferrara Richerche Verfahren zur modulierung der proliferation von medullären schilddrüsen-karzinomzellen
HUP0401535A3 (en) * 2001-03-08 2009-07-28 Univ Tulane Somatostatin antagonists and their use
EP1522311A1 (de) * 2003-10-10 2005-04-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Verwendung von Somatostatin oder seine Derivate zur Herstellung eines Medikamentes zur Regulierung der Ovarialfollikelnreserve bei der nicht menopausierte Frau

Also Published As

Publication number Publication date
WO2005034989A2 (fr) 2005-04-21
US20100152102A1 (en) 2010-06-17
JP5582477B2 (ja) 2014-09-03
DE602004005229D1 (de) 2007-04-19
EP1680139A2 (de) 2006-07-19
RU2418604C2 (ru) 2011-05-20
RU2418604C9 (ru) 2011-07-27
RU2006115606A (ru) 2007-11-27
EP1522311A1 (de) 2005-04-13
JP5572280B2 (ja) 2014-08-13
CA2542054C (fr) 2013-11-26
WO2005034989A3 (fr) 2005-06-16
ATE355851T1 (de) 2007-03-15
US20110003749A2 (en) 2011-01-06
US7648961B2 (en) 2010-01-19
DE602004005229T2 (de) 2008-04-17
DK1680139T3 (da) 2007-07-02
CA2542054A1 (fr) 2005-04-21
JP2007508278A (ja) 2007-04-05
EP1680139B1 (de) 2007-03-07
ES2284067T3 (es) 2007-11-01
US20070155659A1 (en) 2007-07-05
JP2011256178A (ja) 2011-12-22
PT1680139E (pt) 2007-06-12

Similar Documents

Publication Publication Date Title
Hutchings et al. Growth and maintenance of HeLa cells in serum-free medium supplemented with hormones.
PL1680139T3 (pl) Zastosowanie somatostatyny lub jej analogów do wytwarzania leku przeznaczonego do regulowania rezerwy pęcherzyków jajnikowych u kobiet w wieku niemenopauzalnym
WO2002064748A3 (en) Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
MX2007012279A (es) Metodo para regular tejido queratinoso de mamifero.
WO2001078754A3 (en) Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
MX345394B (es) Modulacion de la diferenciacion de celulas madre y progenitoras, ensayos y usos de las mismas.
HK1120522A1 (en) Cell growth inhibitors containing anti-glypican 3 antibody
WO2003087333A8 (en) Modulation of stem and progenitor cell differentiation, assays, and uses thereof
PT1104294E (pt) Composicoes e metodos de tratamento da proliferacao celular anormal
RU2009100930A (ru) Лекарственные средства для стимуляции роста гемопоэтических стволовых клеток
MXPA05004225A (es) Anticuerpos de neutralizacion contra gdf-8, y sus usos.
DE60326490D1 (de) Verwendung von gnrh-agonisten zur unterstützung der lutealphase während einer unfruchtbarkeitsbehandlung
RU2008128451A (ru) Композиция для лечения и ухода за кожей, способ ее получения, способ ее использования
BRPI0318680B8 (pt) composição de ácido hialurônico (ha), método para preparar a composição e para estabilizar ácido hialurônico (ha) reticulado
NZ597965A (en) Methods of preparing and using stem cell compositions and kits comprising the same
AU2001237417A1 (en) Method for isolating sponge collagen and producing nanoparticulate collagen, andthe use thereof
JP2001526560A (ja) 養毛方法
Grabbe et al. Release of stem cell factor from a human keratinocyte line, HaCaT, is increased in differentiating versus proliferating cells
AU8180001A (en) Human growth hormone to stimulate mobilization of pluripotent hematopoietic stemcells
CA2495008A1 (en) Surgery fixation forceps
WO2002000183A3 (en) Use of egf-r protein tyrosine kinase inhibitors for preventing photoaging in human skin
Escobar et al. Effect of vitamins D and E on the proliferation, viability, and differentiation of human dental pulp stem cells: an in vitro study
IL151196A0 (en) A method for synthesizing leflunomide
DK1419240T3 (da) Fremstilling og anvendelse af humane CD124- og CD116-positive tumorcellelinier til fremstilling af allogene eller semi-allogene immumterapeutika
ES2168845T3 (es) Composicion cosmetica que contiene un componente activo capaz de estimular "in vivo" la produccion de interleuquina 6 (il-6) por los queratinocitos humanos.